Presentations we supply
- Tablet 50 mg
- Tablet 70 mg
- Tablet 100 mg
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for DasatinibReference information
Summarised from the product information for Sprycel. Always follow the product information approved in your own country.
- Active substance
- Dasatinib
- Pharmacotherapeutic group
- Antineoplastic agents, protein kinase inhibitors (ATC code L01EA02)
- Authorised uses
- Newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in chronic phase, adults
- Chronic, accelerated or blast phase CML resistant or intolerant to prior therapy including imatinib, adults
- Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML resistant or intolerant to prior therapy, adults
- Ph+ CML in chronic phase in children, newly diagnosed or after imatinib
- Newly diagnosed Ph+ ALL in children, with chemotherapy
- Storage (unopened)
- Film-coated tablets: no special storage conditions.
- Shelf life (unopened)
- 3 years (tablets and powder for oral suspension, unopened)
- Container and pack
- Tablets: Alu/Alu blisters of 30, 56 or 60, or HDPE bottles of 30 or 60. Oral suspension: 120 ml HDPE bottle with 33 g powder
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Sprycel: www.ema.europa.eu